Defining how oncogenic and developmental mutations of PIK3R1 alter the regulation of class IA phosphoinositide 3-kinases
Authors:
- Gillian L. DornanGDGillian L. Dornan
- Jordan T.B. StarihaJSJordan T.B. Stariha
- Manoj K. RathinaswamyMRManoj K. Rathinaswamy
- Cameron J. PowellCPCameron J. Powell
- Martin J. BoulangerMBMartin J. Boulanger
- John E. BurkeJBJohn E. Burke
Preprint
Abstract
Summary: The class IA PI3Ks are key signalling enzymes composed of a heterodimer of a p110 catalytic subunit and a p85 regulatory subunit, with PI3K mutations being causative of multiple human diseases including cancer, primary immunodeficiencies, and developmental disorders. Mutations in the p85α regulatory subunit encoded by PIK3R1 can both activate PI3K through oncogenic truncations in the iSH2 domain, or inhibit PI3K through developmental disorder mutations in the cSH2 domain. Using a combined biochemical and hydrogen deuterium exchange mass spectrometry approach we have defined the molecular basis for how these mutations activate both the p110α/p110δ catalytic subunits. We find that the oncogenic Q572* truncation of PIK3R1 disrupts all inhibitory inputs, with p110α being hyper-activated compared to p110δ. In addition, we find that the R649W mutation in the cSH2 of PIK3R1 decreases sensitivity to activation by receptor tyrosine kinases. This work reveals novel insight into isoform specific regulation of p110s by p85α. Highlights: - An oncogenic variant of p85α, Q572*, leads to hyper-activation of p110α compared to p110δ - HDX-MS revealed that Q572* leads to disruption of all inhibitory interfaces in p110α - A SHORT syndrome mutation in p85α leads to decreased sensitivity to RTKs for p110α/δKeywords
All Related Versions
- Published version: Structure, 28 (2), 145.
This publication has 65 references indexed in Scilit:
- Mutations in PIK3R1 Cause SHORT SyndromeThe American Journal of Human Genetics, 2013
- Dynamic steps in receptor tyrosine kinase mediated activation of class IA phosphoinositide 3-kinases (PI3K) captured by H/D exchange (HDX-MS)Advances in Biological Regulation, 2013
- Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CANature Genetics, 2012
- De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromesNature Genetics, 2012
- Dynamics of the Phosphoinositide 3-Kinase p110δ Interaction with p85α and Membranes Reveals Aspects of Regulation Distinct from p110αStructure, 2011
- Structure of Lipid Kinase p110β/p85β Elucidates an Unusual SH2-Domain-Mediated Inhibitory MechanismMolecular Cell, 2011
- Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110α and are disrupted in oncogenic p85 mutantsProceedings of the National Academy of Sciences, 2009
- Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K ActivationCancer Cell, 2009
- A frequent kinase domain mutation that changes the interaction between PI3Kα and the membraneProceedings of the National Academy of Sciences, 2009
- SH2 domains recognize specific phosphopeptide sequencesCell, 1993